Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) FCF Margin (2019 - 2025)

Silo Pharma (SILO) has disclosed FCF Margin for 7 consecutive years, with 4328.63% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 76087.0% to 4328.63% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6464.92% through Dec 2025, down 114758.0% year-over-year, with the annual reading at 6464.92% for FY2025, 114758.0% down from the prior year.
  • FCF Margin hit 4328.63% in Q4 2025 for Silo Pharma, up from 5300.93% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 471872.56% in Q4 2021 to a low of 9099.63% in Q1 2025.
  • Historically, FCF Margin has averaged 26337.88% across 5 years, with a median of 4489.23% in 2024.
  • Biggest five-year swings in FCF Margin: skyrocketed 47429629bps in 2021 and later tumbled -47678762bps in 2022.
  • Year by year, FCF Margin stood at 471872.56% in 2021, then plummeted by -101bps to 4915.06% in 2022, then fell by -3bps to 5048.33% in 2023, then fell by -1bps to 5089.49% in 2024, then increased by 15bps to 4328.63% in 2025.
  • Business Quant data shows FCF Margin for SILO at 4328.63% in Q4 2025, 5300.93% in Q3 2025, and 7130.47% in Q2 2025.